Amber Implants today announced it received FDA 510(k) clearance for its VCFix Spinal System to treat vertebral compression ...
Medical Device Network on MSN
FDA clears Amber Implants’ vertebral augmentation system
Amber Implants CEO and co-founder Dr Banafsheh Sajadi said: “The VCFix Spinal System is a groundbreaking vertebral ...
This protection not only validates the uniqueness of our OsteoPearl® technology but also strengthens our ability to bring a truly natural, patient-centered solution to market.” — Dom Messerli, CEO and ...
Supported by Clinical Data Presented at IPOS 2023, Pediatric Indication for OSSIOfiber ® Bio-Integrative Orthopedic Fixation Technology Obviates the Need for a Second Surgery to Remove Metal Implants ...
Certainly you've seen people, especially the elderly, with hunched spines. It's a condition that can be quite painful. While many have associated this with the inevitable process of aging, the truth ...
The L. S. Peery, M.D. Orthopaedic Innovation Center at the Department of Orthopaedics, Spencer Fox Eccles School of Medicine, ...
WOBURN, Mass.--(BUSINESS WIRE)--OSSIO, Inc., a fast-growing orthopedic fixation technology company, on Friday received “breaking” news from the U.S. Food and Drug Administration (FDA): The FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback